Clinical Trials Browser

Urinary Bladder Neoplasms × Pharmacogenomic Variants × Genitourinary × Clear all

NCT03552796 2023-06-26

sEphB4-HSA in Treating Participants With BCG-Unresponsive or Refractory Bladder Cancer

Phase 1 Withdrawn

Urinary Bladder Neoplasms